Medicare Advantage 2024 Plans Dip in Ratings

Medicare Advantage and Medicare Part D plans lose 'star' on the CMS performance score card.

5 wooden blocks with a star on each
(Image credit: Brian A. Jackson, Getty Images)

The Centers for Medicare and Medicaid Services’ (CMS) annual ratings of Medicare Advantage and Part D prescription drug (MA-PD) plans dipped again, to an overall average of 4.04 stars for 2024 plans, the lowest rating since 2021 when the overall average was 4.06 stars.

The agency’s ratings system — based on a one-to-five scale with one star representing poor performance and five the highest — measures the quality of health and drug services that enrollees receive through their MA-PD plans. Plans in 2023 earned a 4.14 average star rating, and those for 2022 rated 4.37 stars.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

To continue reading this article
please register for free

This is different from signing in to your print subscription

Why am I seeing this? Find out more here

Joey Solitro

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration. 

With contributions from